Rheumatology Advance Access published online on August 16, 2005
Rheumatology, doi:10.1093/rheumatology/kei026
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 First Department of Internal Medicine, Sapporo Medical University, School of Medicine, Sapporo, Hokkaido, Japan
* To whom correspondence should be addressed.
Accepted June 10, 2005
Letter to the Editor
Beneficial effects of steroid therapy for Mikulicz's disease
2 First Department of Internal Medicine, Sapporo Medical University, Sapporo, Hokkaido, Japan
M. Yamamoto, E-mail: mocha{at}cocoa.plala.or.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Yamamoto, H. Takahashi, K. Hasebe, C. Suzuki, Y. Naishiro, T. Hayashi, H. Yamamoto, T. Ishida, and Y. Shinomura The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome--expansion of SIPS to the territory of Castleman's disease Rheumatology, July 1, 2009; 48(7): 860 - 862. [Full Text] [PDF] |
||||
